Molecular mechanism of MLL PHD3 and RNA recognition by the Cyp33 RRM domain.
The nuclear protein cyclophilin 33 (Cyp33) is a peptidyl-prolyl cis-trans isomerase that catalyzes cis-trans isomerization of the peptide bond preceding a proline and promotes folding and conformational changes in folded and unfolded proteins. The N-terminal RNA-recognition motif (RRM) domain of Cyp33 has been found to associate with the third plant homeodomain (PHD3) finger of the mixed lineage leukemia (MLL) proto-oncoprotein and a poly(A) RNA sequence. Here, we report a 1.9 A resolution crystal structure of the RRM domain of Cyp33 and describe the molecular mechanism of PHD3 and RNA recognition. The Cyp33 RRM domain folds into a five-stranded antiparallel beta-sheet and two alpha-helices. The RRM domain, but not the catalytic module of Cyp33, binds strongly to PHD3, exhibiting a 2 muM affinity as measured by isothermal titration calorimetry. NMR chemical shift perturbation (CSP) analysis and dynamics data reveal that the beta strands and the beta2-beta3 loop of the RRM domain are involved in the interaction with PHD3. Mutations in the PHD3-binding site or deletions in the beta2-beta3 loop lead to a significantly reduced affinity or abrogation of the interaction. The RNA-binding pocket of the Cyp33 RRM domain, mapped on the basis of NMR CSP and mutagenesis, partially overlaps with the PHD3-binding site, and RNA association is abolished in the presence of MLL PHD3. Full-length Cyp33 acts as a negative regulator of MLL-induced transcription and reduces the expression levels of MLL target genes MEIS1 and HOXA9. Together, these in vitro and in vivo data provide insight into the multiple functions of Cyp33 RRM and suggest a Cyp33-dependent mechanism for regulating the transcriptional activity of MLL.
Hom
Robert A
RA
Department of Pharmacology, University of Colorado Denver School of Medicine, 12801 East 17th Avenue, Aurora, CO 80045, USA.
Chang
Pei-Yun
PY
Roy
Siddhartha
S
Musselman
Catherine A
CA
Glass
Karen C
KC
Selezneva
Anna I
AI
Gozani
Or
O
Ismagilov
Rustem F
RF
Cleary
Michael L
ML
Kutateladze
Tatiana G
TG
D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D018360:Crystallography, X-Ray; D021983:Cyclophilins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D029721:Drosophila Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D004331:Drosophila melanogaster; D005786:Gene Expression Regulation; D006801:Humans; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D051788:Myeloid-Lymphoid Leukemia Protein / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D019906:Nuclear Magnetic Resonance, Biomolecular; D011485:Protein Binding; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D012313:RNA / Q000737:chemistry / Q000378:metabolism; D016415:Sequence Alignment; D014158:Transcription, Genetic
D029721:Drosophila Proteins; D051788:Myeloid-Lymphoid Leukemia Protein; D012313:RNA; D021983:Cyclophilins; C114522:PPIE protein, human; C469868:cyp33 protein, Drosophila
Mol Cell. 2009 Jan 30;33(2):181-91
19187761
Proteins. 2005 Jun 1;59(4):687-96
15815974
Oncogene. 2001 Sep 10;20(40):5695-707
11607819
Nucleic Acids Res. 2002 Feb 15;30(4):958-65
11842107
Trends Mol Med. 2004 Oct;10(10):500-7
15464450
Protein Sci. 2006 Aug;15(8):1873-82
16877709
Biopolymers. 2006;84(2):125-46
16302169
Front Biosci. 2005 Jan 01;10:385-97
15574377
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8342-7
12829790
Acta Crystallogr D Biol Crystallogr. 2008 Jan;64(Pt 1):125-32
18094476
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
J Biol Chem. 2008 Nov 21;283(47):32162-75
18829457
EMBO J. 2006 Oct 4;25(19):4503-12
16990798
Cancer Res. 2008 Aug 1;68(15):6199-207
18676843
Mol Cell. 2005 Sep 16;19(6):849-56
16168379
J Biol Chem. 2008 Nov 21;283(47):32158-61
18829459
Mol Cell Biol. 2001 May;21(10):3589-97
11313484
EMBO J. 2006 Nov 1;25(21):5126-37
17036044
Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21
9757107
Blood. 2008 Dec 1;112(12):4690-3
18796627
Nucleic Acids Res. 2002 Apr 1;30(7):1531-8
11917013
Mol Cell. 2002 Nov;10(5):1119-28
12453419
Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7286-91
9207083
J Mol Biol. 2008 Jul 4;380(2):303-12
18533182
Mol Cell. 2002 Nov;10(5):1107-17
12453418
Nat Struct Mol Biol. 2006 Sep;13(9):852-4
16892064
Nature. 2006 Jul 6;442(7098):100-3
16728977
J Biomol NMR. 1995 Nov;6(3):277-93
8520220
Curr Opin Struct Biol. 2008 Jun;18(3):290-8
18515081
Acta Crystallogr D Biol Crystallogr. 1999 Oct;55(Pt 10):1718-25
10531521
FEBS Lett. 2008 Mar 5;582(5):835-9
18258190
Biochemistry. 1991 Mar 19;30(11):2968-76
1848781
J Biol Chem. 2008 Dec 12;283(50):35258-64
18840606
FEBS Lett. 1996 Dec 2;398(2-3):201-5
8977107
Mol Cell Biol. 2001 Apr;21(7):2249-58
11259575
Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19243-8
17159147
Biochemistry. 1996 Mar 19;35(11):3545-54
8639505